Cargando…
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance
Malignant melanoma, with its increasing incidence and high potential to form metastases, is one of the most aggressive types of skin malignancies responsible for a significant number of deaths worldwide. However, melanoma also demonstrates a high potential for induction of a specific adaptive anti-t...
Autores principales: | Kwiatkowska, Dominika, Mazur, Ewelina, Reich, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198644/ https://www.ncbi.nlm.nih.gov/pubmed/35719931 http://dx.doi.org/10.3389/fonc.2022.856963 |
Ejemplares similares
-
Beyond PD-1 Immunotherapy in Malignant Melanoma
por: Kwiatkowska, Dominika, et al.
Publicado: (2019) -
Photodynamic Therapy in Pigmented Basal Cell Carcinoma—A Review
por: Mazur, Ewelina, et al.
Publicado: (2023) -
Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022) -
Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020) -
Convolutional neural networks for the detection of malignant melanoma in dermoscopy images
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)